FI20011542L - Urosognaasigeenin monistuman käyttö - Google Patents
Urosognaasigeenin monistuman käyttöInfo
- Publication number
- FI20011542L FI20011542L FI20011542A FI20011542A FI20011542L FI 20011542 L FI20011542 L FI 20011542L FI 20011542 A FI20011542 A FI 20011542A FI 20011542 A FI20011542 A FI 20011542A FI 20011542 L FI20011542 L FI 20011542L
- Authority
- FI
- Finland
- Prior art keywords
- gene amplification
- sognase
- male
- carcinomas
- relates
- Prior art date
Links
- 230000004544 DNA amplification Effects 0.000 title abstract 3
- 201000009030 Carcinoma Diseases 0.000 abstract 3
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 abstract 2
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 abstract 2
- 229960005356 urokinase Drugs 0.000 abstract 2
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 206010060862 Prostate cancer Diseases 0.000 abstract 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 239000003550 marker Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20011542A FI20011542L (fi) | 2001-07-13 | 2001-07-13 | Urosognaasigeenin monistuman käyttö |
| PCT/FI2002/000636 WO2003006690A1 (en) | 2001-07-13 | 2002-07-15 | Use of urokinase gene amplification as a marker |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20011542A FI20011542L (fi) | 2001-07-13 | 2001-07-13 | Urosognaasigeenin monistuman käyttö |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI20011542A0 FI20011542A0 (fi) | 2001-07-13 |
| FI20011542L true FI20011542L (fi) | 2003-01-14 |
Family
ID=8561659
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI20011542A FI20011542L (fi) | 2001-07-13 | 2001-07-13 | Urosognaasigeenin monistuman käyttö |
Country Status (2)
| Country | Link |
|---|---|
| FI (1) | FI20011542L (fi) |
| WO (1) | WO2003006690A1 (fi) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2886946B1 (fr) * | 2005-06-09 | 2007-08-10 | Biomerieux Sa | Procede pour le diagnoctic/pronostic du cancer du sein |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5422090A (en) * | 1984-08-13 | 1995-06-06 | Biotechnology Australia, Pty., Ltd. | Human PAI-2 |
| JP3653469B2 (ja) * | 1997-11-25 | 2005-05-25 | ジェネンテック・インコーポレーテッド | 線維芽細胞増殖因子−１９ |
-
2001
- 2001-07-13 FI FI20011542A patent/FI20011542L/fi unknown
-
2002
- 2002-07-15 WO PCT/FI2002/000636 patent/WO2003006690A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FI20011542A0 (fi) | 2001-07-13 |
| WO2003006690A1 (en) | 2003-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001051628A3 (en) | Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| WO2001060860A3 (en) | Genes differentially expressed in human prostate cancer and their use | |
| HK1148783A1 (zh) | 用於乳房腺的預後的基因表達標記 | |
| WO2003072125A8 (en) | Therapeutic and diagnostic targeting of cancers cells with tumor homing peptides | |
| ZA200702973B (en) | Disubstituted pyrazolobenzodiazepines useful as inhibitors for CDK2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer | |
| WO2003009814A3 (en) | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer | |
| WO2003004989A3 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| WO2001070979A3 (en) | Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer | |
| MXPA03003281A (es) | Deteccion enzimatica no invasiva de estados asociados con la remodelacion de tejidos. | |
| ATE423191T1 (de) | Prostata stammzellantigen (psca) und dessen verwendungen | |
| EP1893196A4 (en) | DIARYLHYDANTOIN CONNECTIONS | |
| WO2005123993A3 (en) | Phage microarray profiling of the humoral response to disease | |
| WO2006095086A8 (fr) | Traçabilite des anomalies du cycle cellulaire ciblant l'oncologie et la neurodegenerescence. | |
| WO2006028655A3 (en) | Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer | |
| MXPA05008794A (es) | Antigeno de glicoproteina sima135 expresado en celulas tumorales humanas metastasicas. | |
| WO2005053604A3 (en) | Antibodies specific for cancer associated antigen sm5-1 and uses thereof | |
| HUP0303649A2 (hu) | Mátrix-metalloproteináz-inhibitorok liposzómás célzása | |
| EP1377596A4 (en) | USE OF THE TTK FOR DIAGNOSTIC PURPOSES AND AS A THERAPEUTIC TARGET OF CANCER | |
| DK1485345T3 (da) | Urokinaseinhibitorer, deres fremstilling og anvendelse | |
| FR2875601B1 (fr) | Vimentine phosphorylee comme marqueur de l'agressivite et/ou l'invasivite des tumeurs | |
| WO2001046697A3 (en) | Identification, assessment, prevention, and therapy of breast cancer | |
| EP1451552A4 (en) | FOR DETECTING DISORDERS OF BREAST SUITABLE REAGENTS AND METHODS | |
| WO2004031402A3 (en) | Methylation profile of cancer | |
| WO2002046765A3 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer | |
| TW200517122A (en) | Antibodies specific for cancer associated antigen SM5-1 and uses thereof |